Kelly Carmichael
Nurse Practitioner · Ann Arbor, MINPI 1669836979
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 8.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,485, 5.2 times the $478 reported in 2021. Among nurse practitioner clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $92.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$540
- Amgen$488
- Teva Pharmaceuticals USA, Inc.$382
- Alnylam Pharmaceuticals Inc.$358
- GSK$335
- Novo Nordisk$323
- plus $4K from 29 others
What the payments were for
- Food & beverage$6,225100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 5 | $540 |
| Amgen | 4 | $488 |
| Teva Pharmaceuticals USA, Inc. | 4 | $382 |
| Alnylam Pharmaceuticals Inc. | 3 | $358 |
| GSK | 3 | $335 |
| Novo Nordisk | 5 | $323 |
| Boston Scientific | 2 | $284 |
| AbbVie | 3 | $280 |
| Jazz Pharmaceuticals Inc. | 2 | $244 |
| Axsome Therapeutics, Inc. | 3 | $241 |
| Bayer | 3 | $190 |
| Corcept Therapeutics | 2 | $180 |
| Pfizer | 3 | $165 |
| E.r. Squibb & Sons, L.L.C. | 2 | $160 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $151 |
| Lundbeck LLC | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $122 |
| Mayne Pharma Commercial LLC | 1 | $122 |
| Catalyst Pharmaceuticals, Inc. | 1 | $121 |
| Sanofi | 1 | $116 |
| Gilead | 1 | $112 |
| Edwards Lifesciences | 1 | $106 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $101 |
| Exact Sciences | 1 | $99 |
| Molnlycke Health Care US, LLC | 2 | $96 |
| Optinose US, Inc. | 1 | $95 |
| Shield Therapeutics Inc | 1 | $93 |
| Amarin Pharma, Inc. | 1 | $89 |
| Sage Therapeutics, LLC | 1 | $86 |
| Johnson & Johnson | 1 | $86 |
| SK Life Science, Inc. | 1 | $72 |
| CMP Pharma, Inc. | 1 | $63 |
| Scynexis, Inc. | 1 | $46 |
| Medtronic | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMVUTTRA$260
- BENLYSTA$250
- Epidiolex$244
- WaveWriter Alpha Prime 16$150
- ULTOMIRIS$135
- WATCHMAN FLX$134
- NURTEC ODT$125
- VYEPTI$125
- VRAYLAR$125
- EVENITY$125
- SOLIRIS$123
- Prolia$122
- Repatha$122
- Wegovy$122
- NEXTSTELLIS$122
- Veozah$122
- UZEDY$122
- FIRDAPSE$121
- ELIQUIS$119
- TEPEZZA$119
How this compares
$6,225 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Ann Arbor
- Susanne Mc DevittAnn Arbor$23K
- Jennifer DubnickiAnn Arbor$19K
- Ashley KliszAnn Arbor$19K
- Caitlin BoyakAnn Arbor$14K
- Rebecca PriebeAnn Arbor$13K
- Kimberly DimariaAnn Arbor$12K
- Christopher NaismithAnn Arbor$10K
- Diane BohnAnn Arbor$8K
- Davida KrugerDetroit$739K
- Kari HillSpring Lake$426K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.